179 related articles for article (PubMed ID: 19685931)
1. Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.
Radovits BJ; Kievit W; Laan RF
Drugs Aging; 2009; 26(8):647-64. PubMed ID: 19685931
[TBL] [Abstract][Full Text] [Related]
2. Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs.
Sugihara T; Harigai M
Drugs Aging; 2016 Feb; 33(2):97-107. PubMed ID: 26833350
[TBL] [Abstract][Full Text] [Related]
3. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.
Dixon WG; Symmons DP
Ann Rheum Dis; 2007 Sep; 66(9):1132-6. PubMed ID: 17251223
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Anti-TNFα Agents: The Example of Ozoralizumab.
Tsumoto K; Takeuchi T
BioDrugs; 2024 May; 38(3):341-351. PubMed ID: 38584236
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment.
Deng Y; Zheng H; Li B; Huang F; Qiu Y; Yang Y; Sheng W; Peng C; Tian X; Wang W; Yu H
J Control Release; 2024 Jul; 371():498-515. PubMed ID: 38849090
[TBL] [Abstract][Full Text] [Related]
6. A Review of the Occurrence of Rheumatoid Arthritis and Potential Treatments through Medicinal Plants from an Indian Perspective.
Shekh MR; Ahmed N; Kumar V
Curr Rheumatol Rev; 2024; 20(3):241-269. PubMed ID: 38018201
[TBL] [Abstract][Full Text] [Related]
7. The use of anti-TNFα medications for rheumatologic disease in pregnancy.
Clowse ME
Int J Womens Health; 2010 Aug; 2():199-209. PubMed ID: 21072312
[TBL] [Abstract][Full Text] [Related]
8. Biologic monotherapy in the treatment of rheumatoid arthritis.
Detert J; Klaus P
Biologics; 2015; 9():35-43. PubMed ID: 26028960
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of neurological sarcoidosis.
Lower EE; Broderick JP; Brott TG; Baughman RP
Arch Intern Med; 1997 Sep; 157(16):1864-8. PubMed ID: 9290546
[TBL] [Abstract][Full Text] [Related]
10. Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo S; Miyazaki Y; Todoroki Y; Nagayasu A; Kanda R; Aritomi T; Matsunaga S; Ueno M; Miyagawa I; Sonomoto K; Hanami K; Nakayamada S; Tanaka Y
Rheumatol Ther; 2023 Dec; 10(6):1705-1723. PubMed ID: 37856034
[TBL] [Abstract][Full Text] [Related]
11. Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort).
Oishi S; Wendling D; Sibilia J; Job-Deslandre C; Guillevin L; Benichou J; Flipo RM; Duquenne C; Guillemin F; Saraux A
Hum Vaccin Immunother; 2018; 14(11):2612-2617. PubMed ID: 30230962
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis.
Fleischmann R; Alam J; Arora V; Bradley J; Schlichting DE; Muram D; Smolen JS
RMD Open; 2017; 3(2):e000546. PubMed ID: 29071120
[No Abstract] [Full Text] [Related]
13. Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study.
Morsley K; Kilner T; Steuer A
Rheumatol Ther; 2015 Dec; 2(2):165-172. PubMed ID: 27747537
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations.
Toussirot É
Drugs Aging; 2015 Jul; 32(7):515-24. PubMed ID: 26123949
[TBL] [Abstract][Full Text] [Related]
15. Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management.
Goodman SM
Drugs Aging; 2015 May; 32(5):361-9. PubMed ID: 25941102
[TBL] [Abstract][Full Text] [Related]
16. [Safety of antirheumatic drug treatment in the elderly].
Krüger K; Strangfeld A; Kneitz C
Z Rheumatol; 2014 Apr; 73(3):244-50. PubMed ID: 24676590
[TBL] [Abstract][Full Text] [Related]
17. Unmet needs in autoimmunity and potential new tools.
Lu Q
Clin Rev Allergy Immunol; 2014 Oct; 47(2):111-8. PubMed ID: 24595881
[TBL] [Abstract][Full Text] [Related]
18. The fundamental unit of pain is the cell.
Reichling DB; Green PG; Levine JD
Pain; 2013 Dec; 154 Suppl 1():S2-9. PubMed ID: 23711480
[TBL] [Abstract][Full Text] [Related]
19. Clinical and radiological presentations of late-onset spondyloarthritis.
Hmamouchi I; Bahiri R; Hajjaj-Hassouni N
ISRN Rheumatol; 2011; 2011():840475. PubMed ID: 23509636
[TBL] [Abstract][Full Text] [Related]
20. Time trends in medication use and expenditures in older patients with rheumatoid arthritis.
Harrold LR; Peterson D; Beard AJ; Gurwitz JH; Briesacher BA
Am J Med; 2012 Sep; 125(9):937.e9-15. PubMed ID: 22682794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
